Major Histocompatibility Complex (MHC)

The major histocompatibility complex (MHC, the HLA system in humans) is the antigen-presentation machinery of adaptive immunity: cell-surface glycoproteins that bind peptide fragments intracellularly and display them at the surface for inspection by T-cell receptors. Class I molecules (HLA-A, -B, -C) show endogenous peptides to CD8 T cells on nearly every cell; class II molecules (HLA-DR, -DP, -DQ) show endocytosed peptides to CD4 cells on professional antigen-presenting cells. The system's staggering polymorphism — the most variable loci in the human genome — balances pathogen coverage against autoimmunity and dictates transplantation compatibility.

Gene
HLA-A/B/C (class I); HLA-DR/DQ/DP (class II) on chromosome 6p21
Family
Immunoglobulin superfamily (MHC fold)
Location
All nucleated cells (I); APCs — dendritic, B, macrophage (II)
Structure
Class I: heavy chain + β2-microglobulin; class II: α/β heterodimer
Binding Partners
Peptides (8–10 aa class I, 13–17 aa II), TCR, CD8/CD4 co-receptors

Structure

Function

Regulation

Interactions

Clinical Relevance

Sources